Initiation of Lithium Therapy
Start lithium at 300 mg three times daily (or 450-900 mg/day based on age) in adults, targeting a serum level of 0.6-0.8 mEq/L for maintenance, with twice-weekly level monitoring during acute titration and comprehensive baseline laboratory assessment including renal function, thyroid function, complete blood count, electrolytes, calcium, urinalysis, and pregnancy testing in women of childbearing age 1, 2, 3.
Contraindications
Before initiating lithium, exclude patients with significant renal or cardiovascular disease, severe debilitation, dehydration, sodium depletion, or those on diuretics, as lithium toxicity risk is extremely high 1. If the psychiatric indication is life-threatening and other treatments have failed, lithium may be used only with hospitalization, daily serum level monitoring, and reduced dosing 1.
Starting Dose Protocol
Age-Based Dosing
- Adults <40 years: 12-24 mmol/day (450-900 mg lithium carbonate daily), typically 300 mg three times daily 1, 3
- Adults 40-60 years: Target 20-25 mmol/day (740-925 mg) for maintenance 3
- Adults >60 years: Target 15-20 mmol/day (550-740 mg) for maintenance; elderly patients often require reduced doses and may show toxicity at levels tolerated by younger patients 1, 3
Acute Mania vs. Maintenance
- Acute mania: 600 mg three times daily to achieve serum levels of 1.0-1.5 mEq/L 1
- Long-term maintenance: 300 mg three to four times daily targeting 0.6-0.8 mEq/L (consensus from multiple guidelines) or up to 1.2 mEq/L per some sources 1, 4
Recent evidence from Asian populations suggests mean lithium levels >0.50 mEq/L are associated with increased thyroid dysfunction and >0.59 mEq/L with chronic kidney disease, supporting the lower end of the therapeutic range 5.
Serum Level Monitoring
Timing and Frequency
- During acute phase: Check lithium levels twice weekly until stable 1
- Maintenance phase: Monitor every 2 months in uncomplicated cases 1
- Sample timing: Draw blood 8-12 hours after the previous dose (trough level), ideally 12 hours post-dose 3, 6
Target Levels
- Maintenance treatment: 0.6-0.8 mEq/L (strongest consensus) 4, 7
- Older adults (≥60 years): Target 0.47-0.67 mEq/L; levels of 0.82-1.00 mEq/L associated with increased side effects 7
- Sustained-release preparations: May target 0.8-1.0 mEq/L due to later peak concentrations 3
Baseline Laboratory Assessment
Before starting lithium, obtain 2:
- Complete blood count
- Thyroid function tests (TSH, free T4)
- Renal function: BUN, creatinine, urinalysis
- Serum calcium (to screen for baseline parathyroid issues)
- Serum electrolytes
- Pregnancy test in females of childbearing age
Ongoing Monitoring Schedule
Every 3-6 Months
- Lithium serum level
- Renal function (creatinine, BUN, urinalysis)
- Thyroid function (TSH, free T4)
- Serum calcium 2, 8
Additional Considerations
- Weight and metabolic monitoring: If combining with atypical antipsychotics, follow metabolic monitoring protocols 2
- Clinical monitoring: Do not rely solely on laboratory values; assess clinical response and side effects regularly 1
Dosing Schedule Considerations
Once-daily evening dosing is increasingly recommended over traditional three-times-daily schedules, as compliance with midday doses is questionable and modern sustained-release preparations support this approach 3. If using once-daily dosing, draw trough levels at 24 hours post-dose rather than 12 hours.
Critical Drug Interactions
Exercise extreme caution with:
- Diuretics: Significantly increase lithium toxicity risk 1
- ACE inhibitors: Require closer monitoring 7
- NSAIDs: Decrease lithium clearance and increase toxicity risk 7
These interactions typically decrease lithium clearance, necessitating dose reduction and more frequent monitoring 3.
Titration Duration
Allow 6-8 weeks at adequate doses before concluding treatment failure or adding additional mood stabilizers 2. Lithium reaches steady-state in approximately 5 days (based on 18-36 hour half-life), but clinical response requires longer assessment 3.
Special Populations
Pregnancy
Lithium clearance increases 30-50% during the last months of pregnancy due to increased glomerular filtration rate, requiring dose adjustments 3. Lithium passes freely into breast milk 3.
Renal Impairment
Renal insufficiency substantially reduces lithium clearance and is generally considered a contraindication 1, 3. If treatment is essential, use only with hospitalization and daily level monitoring 1.
Common Pitfalls
- Relying solely on serum levels: Clinical assessment is essential; some patients show toxicity at "therapeutic" levels 1
- Inadequate hydration counseling: Dehydration dramatically increases toxicity risk 1
- Missing drug interactions: Always review concomitant medications, especially diuretics and NSAIDs
- Insufficient monitoring frequency: The narrow therapeutic window demands vigilant monitoring, particularly during initiation and dose changes
- Ignoring early toxicity signs: Educate patients on symptoms (tremor, confusion, polyuria) as periodic monitoring may miss acute changes 2